Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2654

Actual shortage: 249 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2396 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

329 (11%)

Overdue reports

26 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-DILTIAZEM XC 300MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-18 2024-04-25 216466
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2024-02-08 2024-03-07 218983
TEVA-DILTIAZEM XC 360MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-07 2024-04-25 221546
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-18 2024-03-21 222572
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-28 2024-04-05 223856
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-28 2024-04-25 223862
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-04-05 2024-04-25 224445
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-04-18 2024-04-18 225492
TEVA-ZOLMITRIPTAN OD 2.5MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-13 2020-02-13 1674
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-17 2018-06-15 3357
TEVA-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-10 2017-09-19 9805
ACT OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-24 2018-06-15 10972
ACT OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-24 2018-10-11 10975
TEVA-RIZATRIPTAN ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-08-22 2019-09-19 92151
TEVA-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-08-22 2019-11-21 92154
ACT OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-09-05 2019-10-26 93156
ACT OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-01-24 99965
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-01-24 99968
ACT ESCITALOPRAM ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-02-21 99971
ACT ESCITALOPRAM ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-02-21 99974

Showing 2621 to 2640 of 2654

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
LEUCOVORIN CALCIUM INJECTION 10MG SOLUTION Discontinued 2017-06-27 2017-06-27 14036
TEVA-RANITIDINE SOLUTION 15MG SOLUTION Discontinued 2019-04-11 2019-04-11 81304
VINORELBINE TARTRATE FOR INJECTION 10MG SOLUTION To be discontinued 2019-07-05 2019-07-05 88619
VINORELBINE TARTRATE FOR INJECTION 10MG SOLUTION Discontinued 2019-09-27 2019-10-01 94980
VINORELBINE TARTRATE FOR INJECTION 10MG SOLUTION Discontinued 2019-10-17 2019-10-17 96695
TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION 0.004% SOLUTION Discontinued 2020-01-21 2020-01-21 103788
TEVA-LATANOPROST 50MCG SOLUTION Discontinued 2020-07-10 2020-07-10 120009
EPIRUBICIN FOR INJECTION 2MG SOLUTION Discontinued 2020-10-22 2020-10-24 126906
TEVA-NYSTATIN 100000UNIT SUSPENSION Discontinued 2018-10-12 2018-10-12 63946
TEVA-NYSTATIN 100000UNIT SUSPENSION Discontinued 2018-10-12 2018-10-12 63949
TEVA-PRAMIPEXOLE 1.5MG TABLET Discontinued 2017-06-27 2017-06-27 14007
TEVA-FUROSEMIDE 20MG TABLET Discontinued 2017-06-27 2017-06-27 14039
TEVA-FUROSEMIDE 40MG TABLET Discontinued 2017-06-27 2017-06-27 14042
TEVA-CIPROFLOXACIN 500MG TABLET Discontinued 2017-06-27 2017-06-27 14049
TEVA-CARBAMAZEPINE 200MG TABLET Discontinued 2017-06-27 2017-06-27 14052
TEVA-NAPROXEN 250MG TABLET Discontinued 2017-06-27 2017-06-27 14055
TEVA-TRIAMTERENE/HCTZ 25MG 50MG TABLET Discontinued 2017-06-27 2017-06-27 14060
TEVA-LISINOPRIL/HCTZ (TYPE P) 12.5MG 10MG TABLET Discontinued 2018-10-12 2018-10-12 63975
TEVA-LISINOPRIL (TYPE P) 20MG TABLET Discontinued 2018-10-12 2018-10-12 63978
TEVA-ATORVASTATIN 40MG TABLET Discontinued 2018-10-17 2018-10-17 64538

Showing 101 to 120 of 250